228 related articles for article (PubMed ID: 28768224)
1. IgG4-related hypertrophic pachymeningitis of the spine with MPO-ANCA seropositivity.
Maher M; Zanazzi G; Faust P; Nickerson K; T Wong T
Clin Imaging; 2017; 46():108-112. PubMed ID: 28768224
[TBL] [Abstract][Full Text] [Related]
2. A case of MPO- and PR3-ANCA-positive hypertrophic cranial pachymeningitis with elevated serum IgG4.
Iguchi A; Wada Y; Kobayashi D; Sato H; Oyama T; Nakatsue T; Murakami S; Kuroda T; Nakano M; Narita I
Mod Rheumatol; 2013 Jan; 23(1):151-5. PubMed ID: 22350578
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.
Yokoseki A; Saji E; Arakawa M; Kosaka T; Hokari M; Toyoshima Y; Okamoto K; Takeda S; Sanpei K; Kikuchi H; Hirohata S; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
Brain; 2014 Feb; 137(Pt 2):520-36. PubMed ID: 24271323
[TBL] [Abstract][Full Text] [Related]
4. [IgG4- and MPO-ANCA-associated hypertrophic pachymeningitis].
Aragonès JM; Arias-Rivero M; García-Barrionuevo JM; Lucchetti G
Rev Neurol; 2015 Nov; 61(10):454-7. PubMed ID: 26553176
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab.
Popkirov S; Kowalski T; Schlegel U; Skodda S
J Clin Neurosci; 2015 Jun; 22(6):1038-40. PubMed ID: 25861887
[TBL] [Abstract][Full Text] [Related]
6. [A case of hypertrophic spinal pachymeningitis associated with MPO-ANCA].
Yakushiji Y; Kurohara K; Toda S; Abe M; Kuroda Y
Rinsho Shinkeigaku; 2002 Sep; 42(9):873-7. PubMed ID: 12710088
[TBL] [Abstract][Full Text] [Related]
7. Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.
Gautier F; Neumann L; Adle-Biassete H; Rubenstein E; Bernat AL; Chimon A; Mouly S; Sène D; Comarmond C
Autoimmun Rev; 2023 Apr; 22(4):103285. PubMed ID: 36738953
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic Pachymeningitis with Characteristics of Both IgG4-related Disorders and Granulomatosis with Polyangiitis.
Mori M; Sakai K; Saito K; Nojima T; Mohri M; Matsubara K; Hayashi S; Yamada M
Intern Med; 2022 Jun; 61(12):1903-1906. PubMed ID: 34803104
[TBL] [Abstract][Full Text] [Related]
9. A Case of Hypertrophic Pachymeningitis Associated with Immunoglobulin-G4 and c-ANCA.
Wyrostek S; Chakrabarti S; Baldwin K; Avila JD
Case Rep Neurol; 2019; 11(3):290-294. PubMed ID: 31762760
[TBL] [Abstract][Full Text] [Related]
10. [Orbital apex syndrome due to relapse during steroid tapering in a patient with MPO-ANCA-positive IgG4-related hypertrophic pachymeningitis].
Iwanami M; Ogawa T; Tanaka Y; Hyoudo A; Ueda Y; Miyamoto T
Rinsho Shinkeigaku; 2014; 54(1):52-5. PubMed ID: 24429649
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 15 cases with myeloperoxidase antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].
Guan WJ; Ding YX; Liu LJ; Li W; Jing LJ; Zhang X; Zhang LJ; Li H; Cheng SH; Liu SY
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):565-569. PubMed ID: 35488609
[TBL] [Abstract][Full Text] [Related]
12. Two cases of hypertrophic pachymeningitis associated with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive pulmonary silicosis in tunnel workers.
Saeki T; Fujita N; Kourakata H; Yamazaki H; Miyamura S
Clin Rheumatol; 2004 Feb; 23(1):76-80. PubMed ID: 14749992
[TBL] [Abstract][Full Text] [Related]
13. P-ANCA cranial pachymeningitis: a case report.
Jacobi D; Maillot F; Hommet C; Arsène S; Cottier JP; Lamisse F; Guillevin L
Clin Rheumatol; 2005 Apr; 24(2):174-7. PubMed ID: 15578248
[TBL] [Abstract][Full Text] [Related]
14. IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review.
Xia C; Li P
Front Neurol; 2022; 13():986694. PubMed ID: 36188377
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic pachymeningitis with MPO-ANCA-positive vasculitis.
Horino T; Takao T; Taniguchi Y; Terada Y
Clin Rheumatol; 2010 Jan; 29(1):111-3. PubMed ID: 19727912
[TBL] [Abstract][Full Text] [Related]
16. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment.
Lu LX; Della-Torre E; Stone JH; Clark SW
JAMA Neurol; 2014 Jun; 71(6):785-93. PubMed ID: 24733677
[TBL] [Abstract][Full Text] [Related]
17. [Unusual visual impairments in a case of MPO-ANCA associated hypertrophic pachymeningitis].
Hayashi S; Sugeno N; Nishiyama S; Hasegawa T; Aoki M
Rinsho Shinkeigaku; 2012; 52(3):152-5. PubMed ID: 22453038
[TBL] [Abstract][Full Text] [Related]
18. [A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated hypertrophic pachymeningitis presenting with multiple cranial nerve palsies and diabetes insipidus].
Yasuda K; Sainouchi M; Goto M; Murase N; Ohtani R; Nakamura M
Rinsho Shinkeigaku; 2016 May; 56(5):334-7. PubMed ID: 27098904
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic pachymeningitis with anti-neutrophil cytoplasmic antibody (p-ANCA), and diabetes insipidus.
Takuma H; Shimada H; Inoue Y; Ishimura E; Himuro K; Miki T; Nishizawa Y
Acta Neurol Scand; 2001 Dec; 104(6):397-401. PubMed ID: 11903097
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis.
Della-Torre E; Galli L; Franciotta D; Bozzolo EP; Briani C; Furlan R; Roveri L; Sessa M; Passerini G; Sabbadini MG
J Neuroimmunol; 2014 Jan; 266(1-2):82-6. PubMed ID: 24289956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
